Local Relationships Matter

Published in Government Relations on March 11, 2025

VGM Group, Inc is proud to announce that Rep. Miller-Meeks (R-IA) and Rep. Feenstra (R-IA) are lead sponsors of the DMEPOS Relief Act (H.R. 2005)! This bill will provide the 75/25 DME Relief and guide our work in the 119th Congress. Working alongside our industry partner, MAMES, VGM has long been cultivating relationships with the Iowa delegation with the hope that they will continue to be champions of change for the home medical equipment industry. Their support of DME suppliers is evident in their continued efforts to lead the passing of equitable reimbursement legislation.

Additional sponsors include Rep. Tonko (D-NY) and Rep. Panetta (D-CA). This gives us two members of Energy & Commerce and two members of Ways & Means championing our cause! 

Both Representatives understand that people want to stay in their homes and live independently. The DME industry provides that opportunity, and we are honored to continue to partner with Rep. Miller-Meeks and Rep. Feenstra to create a robust, efficient, and effective home health experience for all people. 

“Durable medical equipment like wheelchairs, oxygen tanks, walkers, and blood sugar monitors are critical for our seniors and Iowans recovering from surgery. However, our neighbors in rural communities face higher costs for these devices and DME providers often absorb these increased prices because of outdated reimbursement policies. That must change,” said Rep. Feenstra.

 Feenstra John and ikeIke and MMM

"Several years ago, I made a six-hour drive to Hull, IA, to meet with a newly elected Representative. Meeting Representative Feenstra for the first time, I was impressed by his knowledge of healthcare and his commitment to supporting people in their homes. Fast forward to today, and we are thrilled to have Ways & Means member Rep. Feenstra championing the DMEPOS Relief Act (H.R. 2005). Adding to the strong Iowa connection is our friend and champion, Rep. Miller-Meeks. This VGM relationship began at the state level when she served in the Iowa Legislature. VGM is proud to collaborate with our Iowa Representatives, legislators across the country, industry stakeholders, and our members to be true Champions of Change." Ike Isaacson

We encourage you to reach out to your Representative today and ask them to support the DMEPOS Relief Act (H.R. 2005) and become a Champion of Change! Click here to contact your representative and urge them to support this crucial legislation. 

From Our Experts

OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers thumbnail OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers The HHS Office of Inspector General (OIG) recently released a white paper examining ongoing Medicare fraud involving durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help thumbnail Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help The recent HHS Office of Inspector General (OIG) report on DMEPOS fraud signals that CMS is likely to increase oversight activities across the industry. The report calls for enhanced supplier enrollment screening, more aggressive medical reviews, expanded use of artificial intelligence and data analytics, greater physician order verification, and increased scrutiny of supplier ownership and billing practices. CMS Releases Critical Updates On The Medicare Supplier Enrollment Moratorium And Round 2028 Competitive Bidding Program thumbnail CMS Releases Critical Updates On The Medicare Supplier Enrollment Moratorium And Round 2028 Competitive Bidding Program See CMS' notice on the Medicare Supplier Enrollment Moratorium below: Medicare's DMEPOS Supplier Enrollment Moratorium Has Expired | Action Required for Round 2028 Bidders This message is to inform you that the 6-month temporary moratorium on accepting Medicare supplier enrollment applications, which became effective on February 27, 2026, has now expired as of August 27, 2026. CMS Updates CBIC Website Bid Preparation Guidance for Round 2028 Competitive Bidding Program thumbnail CMS Updates CBIC Website Bid Preparation Guidance for Round 2028 Competitive Bidding Program On August 13, 2026, CMS posted several updated and new Fact Sheets and one new FAQ to the Bid Preparation Phase page on the CBIC website. Providers interested in submitting a bid for Round 2028 can find more program details, including the estimated number of contract awards, for each category. Important: HME Supplier Survey on Round 2028 Competitive Bidding Impact thumbnail Important: HME Supplier Survey on Round 2028 Competitive Bidding Impact AAHomecare is conducting a brief survey to help quantify the potential impact that Medicare's Remote Item Delivery (RID) model of Competitive Bidding would have on HME suppliers providing continuous glucose monitors (CGMs), insulin pumps, ostomy supplies, and/or urological supplies. Survey findings will be used to inform discussions with the White House, the Centers for Medicare and Medicaid Services (CMS), and Congress about the potential effects on supplier businesses, jobs, and patient... CMS Makes Finalized Change to DMEPOS Competitive Bidding Program thumbnail CMS Makes Finalized Change to DMEPOS Competitive Bidding Program The Centers for Medicare and Medicaid Services (CMS) has issued the FY 2027 Inpatient Rehabilitation Facilities (IRF) Prospective Payment System (PPS) Final Rule (CMS-1845-F), increasing the DMEPOS Competitive Bidding Program's bid surety bond amount to $100,000 (previously $50,000).... VGM Government Relations Launches State Payer Resource Hub for DMEPOS Providers thumbnail VGM Government Relations Launches State Payer Resource Hub for DMEPOS Providers This resource brings together key information frequently used by DMEPOS providers. Kentucky Governor Announces Reprieve from Previously Announced Kentucky Medicaid 4% Rate Cut thumbnail Kentucky Governor Announces Reprieve from Previously Announced Kentucky Medicaid 4% Rate Cut The administration expects the surplus funding to sustain current reimbursement levels through June 2027.